Transcription repression and blocks in cell cycle progression in hypoplastic left heart syndrome.

Hypoplastic left heart syndrome (HLHS) is characterized by abnormally developed atrial septum and a severe underdevelopment of the left side of the heart. Despite significant advances in its surgical management, little is known about the molecular abnormalities in this syndrome. To gain molecular insights into HLHS, expression profiling by gene-chip microarray (Affymetrix U133 2.0) and by real-time RT-PCR was performed in the atrial septum of patients diagnosed with HLHS and compared with age-matched non-HLHS patients. Hierarchical clustering of all expressed genes with a P < 0.01 of all tissue samples showed two main clusters, one of HLHS and the other of non-HLHS, suggesting different expression patterns by the two groups. Net affix followed by real-time RT-PCR analysis identified the differentially expressed genes to be those involved in chromatin remodeling, cell cycle regulation, and transcriptional regulation. These included remodeling factors, histone deactylase 2 and SET and MYND domain containing 1; transcription factors, FoxP1, and components of the calcineurin-nuclear factor of activated T cells signaling pathway; and cell cycle regulators, cyclin-dependent kinase (CDK)-4, phosphatase and tensin homolog, and p18. Since these factors play essential roles in heart growth and development, the abnormal expression pattern suggests that these molecules may contribute to the pathogenesis of HLHS.

[1]  M. Kilby,et al.  Hypoplastic left heart syndrome , 2009, The Lancet.

[2]  C. Eng,et al.  The nuclear affairs of PTEN , 2008, Journal of Cell Science.

[3]  Lisa J. Martin,et al.  Hypoplastic left heart syndrome is heritable. , 2007, Journal of the American College of Cardiology.

[4]  D. Garry,et al.  Transcriptional pathways direct cardiac development and regeneration. , 2006, Trends in cardiovascular medicine.

[5]  P. Hinds A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation. , 2006, Molecular cell.

[6]  K. Baek Cytokine-regulated protein degradation by the ubiquitination system. , 2006, Current protein & peptide science.

[7]  Xiao-Fan Wang,et al.  Human Rad9 is required for the activation of S‐phase checkpoint and the maintenance of chromosomal stability , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[8]  A. Cook,et al.  Current issues and perspectives in hypoplasia of the left heart , 2005, Cardiology in the Young.

[9]  W. Birchmeier,et al.  Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation , 2004, The Journal of cell biology.

[10]  Bin Wang,et al.  Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation , 2004, Development.

[11]  A. Sancar,et al.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.

[12]  J. Bonventre,et al.  The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain. , 2004, Nucleic acids research.

[13]  A. Liao,et al.  Transcriptional Profiling of the Heart Reveals Chamber-Specific Gene Expression Patterns , 2003, Circulation research.

[14]  K. Boheler,et al.  Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes. , 2003, Cardiovascular research.

[15]  Jaw‐Ji Yang Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest. , 2002, Biochemical and biophysical research communications.

[16]  Philippe Soriano,et al.  Overlapping and Unique Roles for C-Terminal Binding Protein 1 (CtBP1) and CtBP2 during Mouse Development , 2002, Molecular and Cellular Biology.

[17]  L. Field,et al.  Cardiomyocyte cell cycle regulation. , 2002, Circulation research.

[18]  D. Srivastava,et al.  Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis , 2002, Nature Genetics.

[19]  C. Moncman,et al.  Targeted disruption of nebulette protein expression alters cardiac myofibril assembly and function. , 2002, Experimental cell research.

[20]  M. Crossley,et al.  The CtBP family: enigmatic and enzymatic transcriptional co‐repressors , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[21]  A. Nepveu,et al.  Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. , 2001, Gene.

[22]  Brian D. Strahl,et al.  Role of Histone H3 Lysine 9 Methylation in Epigenetic Control of Heterochromatin Assembly , 2001, Science.

[23]  M. Jacobs,et al.  Congenital Heart Surgery Nomenclature and Database Project: hypoplastic left heart syndrome. , 2000, The Annals of thoracic surgery.

[24]  G. Kraft,et al.  A rapid procedure for the quantitation of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects , 1999, Journal of endocrinological investigation.

[25]  G. Brooks,et al.  Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? , 1999, European heart journal.

[26]  A. Otte,et al.  C-Terminal Binding Protein Is a Transcriptional Repressor That Interacts with a Specific Class of Vertebrate Polycomb Proteins , 1999, Molecular and Cellular Biology.

[27]  N. Talner,et al.  Report of the New England Regional Infant Cardiac Program, by Donald C. Fyler, MD, Pediatrics, 1980;65(suppl):375-461. , 1998, Pediatrics.

[28]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[29]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[30]  C. Prives,et al.  High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.

[31]  K. Artzt,et al.  STAR, a gene family involved in signal transduction and activation of RNA. , 1997, Trends in genetics : TIG.

[32]  G. Koh,et al.  Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period. , 1997, Journal of molecular and cellular cardiology.

[33]  M. Franklin,et al.  Cardiomyocyte DNA synthesis and binucleation during murine development. , 1996, The American journal of physiology.

[34]  D. Srivastava,et al.  Molecular Pathways Controlling Heart Development , 1996, Science.

[35]  T. Massaro,et al.  Management of hypoplastic left heart syndrome in a consortium of university hospitals. , 1995, The American journal of cardiology.

[36]  P. Russell,et al.  Cell cycle regulation of human WEE1. , 1995, The EMBO journal.

[37]  M. Shokeir Hypoplastic left heart syndrome: An autosomal recessive disorder , 1971, Clinical Genetics.

[38]  E. Olson,et al.  Control of Cardiac Growth by Histone Acetylation / Deacetylation , 2005 .

[39]  A. Cook The Phenotype During Human Fetal Development , 2005 .

[40]  S. Ho,et al.  The fibrous matrix of ventricular myocardium in hypoplastic left heart syndrome: a quantitative and qualitative analysis. , 2004, The Annals of thoracic surgery.

[41]  K. Hayakawa,et al.  Expression of cofilin isoforms during development of mouse striated muscles , 2004, Journal of Muscle Research & Cell Motility.

[42]  G. Chinnadurai CtBP family proteins: more than transcriptional corepressors. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[43]  M. B. Perryman,et al.  Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[44]  S. Cook,et al.  DNA Microarrays : Implications for Cardiovascular Medicine , 2002 .

[45]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[46]  Giulia Piaggio,et al.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.

[47]  K. Kinzler,et al.  Small changes in expression affect predisposition to tumorigenesis , 2002, Nature Genetics.

[48]  V. Mahdavi,et al.  A new bipartite DNA-binding domain: cooperative interaction between the cut repeat and homeo domain of the cut homeo proteins. , 1994, Genes & development.